7 completed, 5 terminated, 4 unknown, 3 recruiting. 7 Not applicable, 7 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Recruiting 2, Unknown 2, Active not recruiting 1, Suspended 1, Terminated 1 |
| Phase 1 | 7 | Terminated 4, Completed 3 |
| Phase 2 | 6 | Completed 4, Terminated 2 |
Follow Digestive System Neoplasm: new trials by email Literature Review of Digestive System Neoplasm trials Research Report on Digestive System Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Target-specific immunoPET Imaging of Digestive System Carcinoma [68Ga]Ga-DOTA-H2D3, [18F]F-RESCA-RB14, [68Ga]Ga-NOTA-T4 - Malignancy, Digestive Cancer | Not applicable | Recruiting | RenJi Hospital | 400 | 2024-12-04 | 2025-12-31 |
| Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 EO-3021, Ramucirumab (CYRAMZA®), Dostarlimab - Stomach Neoplasm, Gastrointestinal Neoplasms | Phase 1 | Terminated | Elevation Oncology | 88 | 2023-08-10 | 2025-11-14 |
| Gastrointestinal Anastomosis Using MonoPlus® Suture Gastrointestinal Stromal Tumors, Gastrointestinal Neoplasms | Withdrawn | Aesculap AG | 2022-07-01 | 2023-04-05 | ||
| Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors Nutritional psychological interventions and vomit-free management - Digestive System Cancer, Digestive System Neoplasm | Not applicable | Unknown | Renmin Hospital of Wuhan University | 316 | 2022-06-01 | 2024-01-30 |
| OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. Pancreatic Neoplasm, Digestive System Neoplasm | Recruiting | OncoSil Medical Limited | 500 | 2022-04-12 | 2024-04-30 | |
| Retrospective Analysis of Colorectal Cancer Screening Results SDC2 Gene Methylation Test and Q-FIT Test, Colonoscopy and/or pathological examination - Colorectal Cancer, Advanced Adenocarcinoma | Completed | Creative Biosciences (Guangzhou) Co., Ltd. | 822 | 2022-03-29 | 2022-07-29 | |
| A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) THE-630 - Gastrointestinal Stromal Tumors (GIST), Neoplasms, Connective Tissue | Phase 1 / Phase 2 | Terminated | Theseus Pharmaceuticals | 32 | 2022-01-03 | 2024-06-05 |
| Total Versus Partial Omentectomy in the Treatment of Gastric Cancer Partial omentectomy - Stomach Neoplasms, Interleukin | Not applicable | Unknown | University of Debrecen | 300 | 2022-01-01 | 2022-05-20 |
| Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study) Biospecimen Collection - blood and tissue sample collection, Electronic Health Record Review - Appendix Carcinoma by AJCC V8 Stage, Colorectal Carcinoma by AJCC V8 Stage | Not applicable | Suspended | Rutgers, The State University of New Jersey | 30 | 2021-04-29 | 2026-05-04 |
| A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China Multigene Methylation Detection Kit - Colorectal Cancer, Advanced Adenocarcinoma | Completed | Creative Biosciences (Guangzhou) Co., Ltd. | 1273 | 2021-01-26 | 2022-10-21 | |
| MRI DWI None-Gaussian Model Predicting Early Response to Immunotherapy in Digestive System Malignancies: a Prospective Observational Study MRI test - Immunotherapy, Digestive System Neoplasm | Unknown | Peking University | 40 | 2020-09-01 | 2020-08-06 | |
| Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study Biospecimen Collection, Genetic Counseling, Genetic Testing - Breast Carcinoma, Digestive System Neoplasm | Phase 1 | Completed | Mayo Clinic | 230 | 2020-06-29 | 2023-07-24 |
| ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial ctDNA-analysis, Intensified Follow-up Schedule - Colorectal Cancer, Colo-rectal Cancer | Not applicable | Active not recruiting | Claus Lindbjerg Andersen | 359 | 2020-01-01 | 2026-04-29 |
| Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction Ocoxin-Viusid® - Stomach Neoplasm, Gastrointestinal Neoplasms | Phase 2 | Completed | Catalysis SL | 45 | 2018-10-25 | 2024-02-07 |
| Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma Ocoxin-Viusid - Colorectal Neoplasm, Intestinal Neoplasms | Phase 2 | Completed | Catalysis SL | 40 | 2018-10-25 | 2024-02-07 |
| Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors. TG6002, Flucytosine (5-FC, Ancotil) - Colorectal Neoplasm, Digestive System Neoplasm | Phase 1 / Phase 2 | Terminated | Transgene | 51 | 2018-10-16 | 2023-06-23 |
| A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer Nab-paclitaxel, Gemcitabine, Capecitabine - Adenocarcinoma, Pancreatic Neoplasms | Phase 1 / Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 48 | 2018-06-21 | 2024-12-31 |
| C-protein Reactive for the Detection of Anastomotic Leakage After Surgery for Digestive Cancer C-reactive protein - C-Reactive Protein, Anastomotic Leak | Unknown | Moroccan Society of Surgery | 500 | 2018-04-01 | 2022-04-06 | |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors pralsetinib (BLU-667) - RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer | Phase 1 / Phase 2 | Completed | Hoffmann-La Roche | 590 | 2017-03-17 | 2025-05-31 |
| A Clinicobiological Database in Metastatic Digestive Cancers Biological collection - Digestive System Neoplasm | Not applicable | Recruiting | Institut du Cancer de Montpellier - Val d'Aurelle | 200 | 2016-09-12 | 2025-02-12 |
Showing 20 of 22. Sign in to see all of them.
Digestive System Neoplasms (22) · Neoplasms (9) · Gastrointestinal Neoplasms (8) · Digestive System Diseases (7) · Colonic Neoplasms (6) · Colorectal Neoplasms (6) · Stomach Neoplasms (5) · Gastrointestinal Diseases (4) · Head and Neck Neoplasms (4) · Pancreatic Neoplasms (4) · Adenocarcinoma (3) · Colonic Diseases (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Neoplasms by Site (3)
Neoplasms by Site (19) · Digestive System Diseases (15) · Neoplasms (13) · Gastrointestinal Diseases (8) · Intestinal Diseases (6) · Intestinal Neoplasms (6) · Rectal Diseases (6) · Colonic Diseases (5) · Neoplasms by Histologic Type (5) · Gastrointestinal Neoplasms (4) · Pathological Conditions, Signs and Symptoms (4) · Stomach Diseases (4) · Carcinoma (3) · Pathologic Processes (3) · Skin and Connective Tissue Diseases (3)
Ocoxin (2) · 130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Capecitabine (1) · Cisplatin (1) · Early Intervention, Educational (1) · Educational Status (1) · Flucytosine (1) · Gemcitabine (1) · Genetic Counseling (1) · Genetic Testing (1) · Irinotecan (1) · Meditation (1) · Methods (1) · Ramucirumab (1)
Catalysis SL (2) · Creative Biosciences (Guangzhou) Co., Ltd. (2) · Aesculap AG (1) · Albert Einstein College of Medicine (1) · Claus Lindbjerg Andersen (1) · Elevation Oncology (1) · Hoffmann-La Roche (1) · Institut du Cancer de Montpellier - Val d'Aurelle (1) · Mayo Clinic (1) · Moroccan Society of Surgery (1) · OncoSil Medical Limited (1) · Peking University (1) · RenJi Hospital (1) · Renmin Hospital of Wuhan University (1) · Rutgers, The State University of New Jersey (1)
United States (7) · China (6) · France (4) · Spain (4) · Belgium (2) · Cuba (2) · Italy (2) · South Korea (2) · United Kingdom (2) · Denmark (1) · Germany (1) · Hong Kong (1) · Hungary (1) · Japan (1) · Morocco (1)
Alyson Moadel (1) · Anass Majbar, MD (1) · Claus L Andersen, PhD (1) · Dung Le, MD (1) · Henry R Alexander, MD (1) · Lin Shen, professor (1) · Niloy J Samadder (1) · Paul J Ross, MRCP, MBBS (1) · Stew Kroll (1) · Thibault Mazard, MD (1) · Weijun Wei (1) · Wenceslao Vasquez Jimenez, Dr. (1)
PMID 16601440, PMID 20719409, PMID 22072493, PMID 22222249, PMID 23354431, PMID 26626800, PMID 26808342, PMID 27582634, PMID 28017447, PMID 28222970, PMID 30207593, PMID 34118197, PMID 34118198, PMID 35715405, PMID 35962206, PMID 37282666, PMID 37916501, PMID 37934000, PMID 38009200, PMID 40241850, PMID 40639400, PMID 41886723
2014 (1), 2016 (1), P30CA013330 (1), P30CA072720 (1)